Radiotherapeutic and companion imaging agents to target MC1R
US-12508329-B2 · Dec 30, 2025 · US
This page is not indexed by search engines while we improve data quality.
Mclaughlin Mark patents
Mclaughlin Mark is listed as an inventor on 48 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Mclaughlin Mark |
| Total patents | 48 |
| First publication | Jan 15, 2015 |
| Latest publication | Dec 30, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Tumor-infiltrating lymphocytes for adoptive cell therapy
US-12291724-B2 · May 6, 2025 · US
A delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
US-2024189441-A1 · Jun 13, 2024 · US
A delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
US-2024181095-A1 · Jun 6, 2024 · US
Conjugates for immunotherapy
US-2024041972-A1 · Feb 8, 2024 · US
Radiotherapeutic and companion imaging agents to target mc1r
US-2023211022-A1 · Jul 6, 2023 · US
Tumor-infiltrating lymphocytes for adoptive cell therapy
US-11518980-B2 · Dec 6, 2022 · US
Tumor-infiltrating lymphocytes for adoptive cell therapy
US-2022282215-A1 · Sep 8, 2022 · US
Toll-like receptor 2 ligands and methods of making and using thereof
US-11414455-B2 · Aug 16, 2022 · US
Radiotherapeutic and companion imaging agents to target MC1R
US-11406723-B2 · Aug 9, 2022 · US
Recent patents
Latest publications not already listed above.
Cyclic peptide conjugates and methods of use
US-11078235-B2 · Aug 3, 2021 · US
Toll-like receptor 2 ligands and methods of making and using thereof
US-2021230219-A1 · Jul 29, 2021 · US
4'-substituted nucleoside reverse transcriptase inhibitors and preparations thereof
US-2021154221-A1 · May 27, 2021 · US
Toll-like receptor 2 ligands and methods of making and using thereof
US-10793595-B2 · Oct 6, 2020 · US
Conjugates for immunotherapy
US-2020188472-A1 · Jun 18, 2020 · US
Radiotherapeutic and companion imaging agents to target mc1r
US-2020108159-A1 · Apr 9, 2020 · US
Stabilized peptoid-peptide hybrids and uses thereof
US-10556928-B2 · Feb 11, 2020 · US
Conjugates for immunotherapy
US-10449227-B2 · Oct 22, 2019 · US
Toll-like receptor 2 ligands and methods of making and using thereof
US-2019263857-A1 · Aug 29, 2019 · US
Processes for making substituted quinazoline compounds using hydrogen bonding catalysts
US-10392353-B2 · Aug 27, 2019 · US
Tumor-infiltrating lymphocytes for adoptive cell therapy
US-2019177693-A1 · Jun 13, 2019 · US
Cyclic peptide conjugates and methods of use
US-2019092812-A1 · Mar 28, 2019 · US
Stabilized peptoid-peptide hybrids and uses thereof
US-2019040104-A1 · Feb 7, 2019 · US
Stabilized peptoid-peptide hybrids and uses thereof
US-10197575-B2 · Feb 5, 2019 · US
4'-substituted nucleoside reverse transcriptase inhibitors and preparations thereof
US-2019022115-A1 · Jan 24, 2019 · US
Integrin interaction inhibitors for the treatment of cancer
US-2018362583-A1 · Dec 20, 2018 · US
Novel processes for making substituted quinazoline compounds using hydrogen bonding catalysts
US-2018346429-A1 · Dec 6, 2018 · US
Process for preparing Substituted Indole Compounds
US-10131674-B2 · Nov 20, 2018 · US
Toll-like receptor 2 ligands and methods of making and using thereof
US-10118942-B2 · Nov 6, 2018 · US
Integrin interaction inhibitors for the treatment of cancer
US-10059740-B2 · Aug 28, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| H Lee Moffitt Cancer Ct & Res | 33 |
| Univ South Florida | 32 |
| Merck Sharp & Dohme | 10 |
| Univ Arizona | 6 |
| Modulation Therapeutics | 5 |
Top CPC classifications
Most common classification codes across this inventor's patents.